Isabel Anstett-Klein

Title: Isabel Anstett-Klein: Innovator in Pharmaceutical Dosage Forms

Introduction

Isabel Anstett-Klein is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms for active ingredients. With a total of 2 patents to her name, her work has had a notable impact on oral administration methods.

Latest Patents

Isabel's latest patents include innovative formulations that enhance the delivery of pantoprazole. The first patent describes a dosage form containing (S)-pantoprazole as the active ingredient, focusing on oral administration of its magnesium salt. The second patent outlines a similar dosage form for pantoprazole, also emphasizing the magnesium salt for effective oral delivery.

Career Highlights

Isabel Anstett-Klein is currently employed at Takeda GmbH, where she continues to advance her research in pharmaceutical sciences. Her expertise in dosage forms has positioned her as a key player in the industry, contributing to the development of effective medication delivery systems.

Collaborations

Isabel collaborates with Rango Dietrich, working together to innovate and improve pharmaceutical formulations. Their partnership exemplifies the importance of teamwork in driving advancements in the field.

Conclusion

Isabel Anstett-Klein's contributions to pharmaceutical dosage forms highlight her role as an influential inventor in the industry. Her patents reflect her commitment to improving medication delivery, making a significant impact on patient care.